Technical Analysis for TLC - Taiwan Liposome Company, Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Historical TLC trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | -1.47% | |
| Crossed Above 200 DMA | Bullish | -1.47% | |
| Stochastic Buy Signal | Bullish | -1.47% | |
| Pocket Pivot | Bullish Swing Setup | -1.47% | |
| Oversold Stochastic | Weakness | -1.47% | |
| 200 DMA Resistance | Bearish | 9.35% | |
| Lower Bollinger Band Walk | Weakness | 9.35% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 3 days ago |
| Down 1% | 3 days ago |
| 200 DMA Support | 6 days ago |
| Possible NR7 | 6 days ago |
| Rose Above Lower Bollinger Band | 6 days ago |
Get a Trading Assistant
- Earnings date: 05/10/2019
Taiwan Liposome Company, Ltd. Description
Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Drugs Pharmaceutical Products Inflammation Pharmacology Ophthalmic Ophthalmology Drug Delivery Lipid Icos Macular Edema Arthritis Bupivacaine Drug Delivery System Corticosteroid Doxorubicin Fungal Infection Local Anesthetic Liposome Peripheral Arterial Disease Treatment Of Inflammation Amphotericin B
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.65 |
| 52 Week Low | 4.07 |
| Average Volume | 18,344 |
| 200-Day Moving Average | 5.02 |
| 50-Day Moving Average | 5.62 |
| 20-Day Moving Average | 5.51 |
| 10-Day Moving Average | 5.27 |
| Average True Range | 0.28 |
| ADX | 16.24 |
| +DI | 21.93 |
| -DI | 20.43 |
| Chandelier Exit (Long, 3 ATRs ) | 5.25 |
| Chandelier Exit (Short, 3 ATRs ) | 5.76 |
| Upper Bollinger Band | 6.11 |
| Lower Bollinger Band | 4.91 |
| Percent B (%b) | 0.39 |
| BandWidth | 21.81 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.12 |
| MACD Histogram | -0.0247 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.56 | ||||
| Resistance 3 (R3) | 5.58 | 5.54 | 5.53 | ||
| Resistance 2 (R2) | 5.54 | 5.49 | 5.53 | 5.52 | |
| Resistance 1 (R1) | 5.46 | 5.47 | 5.44 | 5.44 | 5.51 |
| Pivot Point | 5.42 | 5.42 | 5.41 | 5.41 | 5.42 |
| Support 1 (S1) | 5.34 | 5.37 | 5.32 | 5.32 | 5.25 |
| Support 2 (S2) | 5.30 | 5.35 | 5.29 | 5.24 | |
| Support 3 (S3) | 5.22 | 5.30 | 5.23 | ||
| Support 4 (S4) | 5.20 |
